An underground economy for unapproved weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.
Investigational Drug Acquiring Traction Online
Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Followers are encouraged to contact these profiles privately for source information, while also obtaining discount codes.
Thriving Commerce on Social Networks
Separately, a robust market exists on Telegram, where groups with numerous of members share “before and after” images, administration instructions and claims of next-day British shipping. Sellers promote the drug there before directing customers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.
Medical Professionals Voice Concerns
However, physicians and chemists have cautions that the sale of what is still an unlicensed drug in the UK is a cause for concern and could lead to individuals administering substances of uncertain source.
Several experts stated the popularity for the experimental drug could be linked to the increasing price of licensed weight loss products such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.
Several influencers try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach medicines, marketing, and consumer regulations, potentially leading to fines, legal action or prison.
Platform Reaction and Material Elimination
According to TikTok, the service has taken down problematic content and prohibited associated hashtags and query recommendations. The organization said it was dedicated to keeping the platform safe and investing in strengthening enforcement strategies.
Digital Marketplace Activities
Research also found communities with up to 9,000 members selling the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, populated with images of weight loss, positive reviews and step-by-step instructions for mixing or administering at residence.
Within minutes of entering one community, a seller posted contact information, where most transactions occur. The vendor sent an guidebook and promised delivery within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None inquired about weight, medical conditions or past usage.
Product Details and Costs
Inside these groups, posts show dark colored parcels with Royal Mail stickers, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with sterile water, or pre-filled pens typically priced at 160 pounds for 20mg. When questioned how long a pen should last, sellers give contradictory answers varying between a several days to “depends on your body”.
Service Moderation and Safety Measures
A representative for Telegram stated it regularly moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are administering substances they cannot confirm. Even if the research behind this drug is sound, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service linked the surge in demand to recent price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But fake treatments are highly risky. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.
Her staff has already encountered individuals harmed by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your health,” said the doctor. “These materials could be contaminated or improperly measured.”
Producer Position
A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly experimental product not yet approved … may expose patients to possibly serious health risks”.
